2017
DOI: 10.1016/s2214-109x(17)30100-6
|View full text |Cite
|
Sign up to set email alerts
|

Progress and challenges in maternal health in western China: a Countdown to 2015 national case study

Abstract: SummaryBackgroundChina is one of the few Countdown countries to have achieved Millennium Development Goal 5 (75% reduction in maternal mortality ratio between 1990 and 2015). We aimed to examine the health systems and contextual factors that might have contributed to the substantial decline in maternal mortality between 1997 and 2014. We chose to focus on western China because poverty, ethnic diversity, and geographical access represent particular challenges to ensuring universal access to maternal care in the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
109
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(122 citation statements)
references
References 47 publications
5
109
2
Order By: Relevance
“…5 Lenalidomide-a more potent and less toxic second-generation immunomodulatory drug-is the only agent approved for post-transplant maintenance on the basis of improved PFS with lenalidomide versus placebo or observation. [6][7][8][9] Moreover, lenalidomide maintenance also prolongs overall survival, reducing risk of death by approximately 25%. 9,10 Prolonged use of lenalidomide, however, is associated with increased risk of cytopenias, diarrhoea, thromboembolic events, and secondary primary malignancies.…”
Section: Oral Proteasome Inhibitor Maintenance For Multiple Myelomamentioning
confidence: 99%
“…5 Lenalidomide-a more potent and less toxic second-generation immunomodulatory drug-is the only agent approved for post-transplant maintenance on the basis of improved PFS with lenalidomide versus placebo or observation. [6][7][8][9] Moreover, lenalidomide maintenance also prolongs overall survival, reducing risk of death by approximately 25%. 9,10 Prolonged use of lenalidomide, however, is associated with increased risk of cytopenias, diarrhoea, thromboembolic events, and secondary primary malignancies.…”
Section: Oral Proteasome Inhibitor Maintenance For Multiple Myelomamentioning
confidence: 99%
“…China met MDG goals regarding early childhood mortality, reducing U5MR from 54.1 per 1000 livebirths in 1990 to 12.5 per 100,000 live births in 2015. Additionally, China met the targets for U5MR fastest, with 10.7 deaths per 1,000 livebirths in 2015 and met MDG 5, reducing MMR from 111.0 deaths per 100,000 livebirths in 1990 to 21.8 per 1000 live births in 2015 [4,5,6,7]. However, significant heterogeneity regarding these mortality rates are found between provinces and counties [8] and many counties which still have maternal mortality ratios greater than SDG targets are in rural areas in western China [6].…”
Section: Introductionmentioning
confidence: 99%
“…However, remarkable inequity exists in the socio-economic development between rural and urban areas, amidst different geographic regions and between ethnic and non-ethnic minority populations; this inequity has a significant impact on disparities in health care access and therefore on overall healthcare metrics of these populations: specifically, western China has a greater proportion of rural and ethnic minority residents, has a lower GDP, and a higher proportion of illiteracy [6].…”
Section: Introductionmentioning
confidence: 99%
“…But uptake of healthcare services varies greatly between maternal populations. Absent or inadequate prenatal care was commonly reported among Chinese women in a study covering the years 1997 to 2015 [17]. …”
Section: Introductionmentioning
confidence: 99%